BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sankyo Company, Ltd. 

3-5-1, Nihonbashi Hon-Cho

Chuo-ku  Tokyo  103-8426  Japan
Phone: 03-5255-7111 Fax:


SEARCH JOBS










 Company News
Hovione Licenses Inhaler Technology for Influenza Drug to Sankyo Company, Ltd. (SKXOF.PK) and Biota Holdings Limited (BTA.AX) 3/5/2007 12:22:01 PM    More...
Daiichi Sankyo, Inc. Subsidiary Applies For Additional Indication For Fentanyl Injection 10/2/2006 10:21:00 AM    More...
Ajinomoto And Sankyo Company, Ltd. (SKXOF.PK) In Joint Development, Manufacture And Marketing Of AJD101, New Diabetes Drug 8/31/2006 9:40:59 AM    More...
Sankyo Company, Ltd. (SKXOF.PK) To Manufacture, Distribute Olmetic Antihypertensive Drug In China 8/14/2006 1:35:25 PM    More...
Sankyo To Manufacture, Distribute Olmetic Antihypertensive Drug In China 8/4/2006 5:51:40 PM    More...
Sankyo Company, Ltd. (SKXOF.PK) To Launch Osteoporosis Treatment Drug In Europe 7/19/2006 2:19:19 PM    More...
Sankyo Company, Ltd. (SKXOF.PK) Selected Evotec OAI (Germany) (EVTG.F) As Assay Development And Screening Partner 4/27/2006 10:28:30 AM    More...
Exelixis, Inc. (EXEL) And Sankyo Company, Ltd. (SKXOF.PK) Sign Collaboration Agreement To Develop Novel Therapies For Cardiovascular Disease; $20 Million Upfront Payment 3/20/2006 10:35:46 AM    More...
MorphoSys AG And Japanese Pharmaceutical Group Daiichi Sankyo Form Broad Alliance To Develop Novel Antibody Therapies 3/16/2006 12:39:34 PM    More...
Eli Lilly and Company (LLY) And Sankyo Company, Ltd. (SKXOF.PK) Release: Study Shows More Potent And More Reliable Platelet Inhibition wWth Prasugrel Compared To Clopidogrel Even In Patients With More Reactive Platelets 3/14/2006 2:33:55 PM    More...
123456